Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Kitada, Tohru, Asakawa, Shuichi, Hattori, Nobutaka, Matsumine, Hiroto, Yamamura, Yasuhiro, Minoshima, Shinsei, Yokochi, Masayuki, Mizuno, Yoshikuni +1 more·1998·Nature

Cited by (196)

Items 101–196 of 196

  1. Autophagy in the renewal, differentiation and homeostasis of immune cells
    Clarke, Alexander J., Simon, Anna Katharina · 2019 · Nature Reviews Immunology
  2. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection
    Chung, Chee Yeun, Seo, Hyemyung, Sonntag, Kai Christian, Brooks, Andrew, Lin, Ling, Isacson, Ole · 2005 · Human Molecular Genetics
  3. High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy
    Hasson, Samuel A., Kane, Lesley A., Yamano, Koji, Huang, Chiu-Hui, Sliter, Danielle A., Buehler, Eugen, Wang, Chunxin, Heman-Ackah, Sabrina M., Hessa, Tara, Guha, Rajarshi et al. · 2013 · Nature
  4. Mitophagy in neurodegeneration and aging
    Fivenson, Elayne M., Lautrup, Sofie, Sun, Nuo, Scheibye-Knudsen, Morten, Stevnsner, Tinna, Nilsen, Hilde, Bohr, Vilhelm A., Fang, Evandro F. · 2017 · Neurochemistry International
  5. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling
    Gorman, Adrienne M. · 2008 · Journal of Cellular and Molecular Medicine
  6. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition
    Yokota, Takanori, Sugawara, Kanako, Ito, Kaoru, Takahashi, Ryosuke, Ariga, Hiroyoshi, Mizusawa, Hidehiro · 2003 · Biochemical and Biophysical Research Communications
  7. Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
    Koprich, James B, Reske-Nielsen, Casper, Mithal, Prabhakar, Isacson, Ole · 2008 · Journal of Neuroinflammation
  8. PINK1 protein in normal human brain and Parkinson's disease
    Gandhi, S. · 2006 · Brain
  9. Repairing mitochondrial dysfunction in disease
    Sorrentino, Vincenzo, Menzies, Keir J., Auwerx, Johan · 2018 · Annual Review of Pharmacology and Toxicology
  10. AMPKα2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation
    Wang, Bei, Nie, Jiali, Wu, Lujin, Hu, Yangyang, Wen, Zheng, Dong, Lingli, Zou, Ming-Hui, Chen, Chen, Wang, Dao Wen · 2018 · Circulation Research
  11. Local gene knockdown in the brain using viral-mediated RNA interference
    Hommel, Jonathan D, Sears, Robert M, Georgescu, Dan, Simmons, Diana L, DiLeone, Ralph J · 2003 · Nature Medicine
  12. Autophagy and neurodegeneration
    Frake, Rebecca A., Ricketts, Thomas, Menzies, Fiona M., Rubinsztein, David C. · 2015 · Journal of Clinical Investigation
  13. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress
    Pickrell, Alicia M., Huang, Chiu-Hui, Kennedy, Scott R., Ordureau, Alban, Sideris, Dionisia P., Hoekstra, Jake G., Harper, J. Wade, Youle, Richard J. · 2015 · Neuron
  14. PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons
    Wood-Kaczmar, Alison, Gandhi, Sonia, Yao, Zhi, Abramov, Andrey S. Y., Miljan, Erik A., Keen, Gregory, Stanyer, Lee, Hargreaves, Iain, Klupsch, Kristina, Deas, Emma et al. · 2008 · PLoS ONE
  15. Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseases
    Alexander, Adanna G., Marfil, Vanessa, Li, Chris · 2014 · Frontiers in Genetics
  16. Oxidative and nitrosative stress in Parkinson's disease
    Tsang, Anthony H.K., Chung, Kenny K.K. · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  17. Intraneuronal dopamine-quinone synthesis: a review
    Sulzer, David, Zecca, Luigi · 1999 · Neurotoxicity Research
  18. AMPK, Mitochondrial Function, and Cardiovascular Disease
    Wu, Shengnan, Zou, Ming-Hui · 2020 · International Journal of Molecular Sciences
  19. Deconstruction for Reconstruction: The Role of Proteolysis in Neural Plasticity and Disease
    Bingol, Baris, Sheng, Morgan · 2011 · Neuron
  20. Individual dopaminergic neurons show raised iron levels in Parkinson disease
    Oakley, A. E., Collingwood, J. F., Dobson, J., Love, G., Perrott, H. R., Edwardson, J. A., Elstner, M., Morris, C. M. · 2007 · Neurology
  21. A neo-substrate that amplifies catalytic activity of Parkinson's-disease-related kinase PINK1
    Hertz, Nicholas T., Berthet, Amandine, Sos, Martin L., Thorn, Kurt S., Burlingame, Al L., Nakamura, Ken, Shokat, Kevan M. · 2013 · Cell
  22. Mitochondrial degradation: Mitophagy and beyond
    Uoselis, Louise, Nguyen, Thanh Ngoc, Lazarou, Michael · 2023 · Molecular Cell
  23. Mitochondrial and lysosomal biogenesis are activated following <scp>PINK</scp> 1/parkin‐mediated mitophagy
    Ivankovic, Davor, Chau, Kai‐Yin, Schapira, Anthony H. V., Gegg, Matthew E. · 2016 · Journal of Neurochemistry
  24. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
    Jiang, Houbo, Ren, Yong, Yuen, Eunice Y., Zhong, Ping, Ghaedi, Mahboobe, Hu, Zhixing, Azabdaftari, Gissou, Nakaso, Kazuhiro, Yan, Zhen, Feng, Jian · 2012 · Nature Communications
  25. Ubiquitination in postsynaptic function and plasticity
    Mabb, Angela M., Ehlers, Michael D. · 2010 · Annual Review of Cell and Developmental Biology
  26. The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age
    Kittappa, Raja, Chang, Wendy W, Awatramani, Rajeshwar B, McKay, Ronald D. G · 2007 · PLoS Biology
  27. Molecular pathogenesis of Parkinson's disease
    Gandhi, Sonia, Wood, Nicholas W. · 2005 · Human Molecular Genetics
  28. A molecular chaperone inducer protects neurons from ER stress
    Kudo, T, Kanemoto, S, Hara, H, Morimoto, N, Morihara, T, Kimura, R, Tabira, T, Imaizumi, K, Takeda, M · 2008 · Cell Death &amp; Differentiation
  29. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis
    Jiang, Houbo, Ren, Yong, Zhao, Jinghui, Feng, Jian · 2004 · Human Molecular Genetics
  30. Are ubiquitination pathways central to Parkinson’s disease?
    Giasson, Benoit I, Lee, Virginia M.-Y · 2003 · Cell
  31. Mitochondrial Medicine for Aging and Neurodegenerative Diseases
    Reddy, P. Hemachandra · 2008 · NeuroMolecular Medicine
  32. Inflammation is genetically implicated in Parkinson’s disease
    Dzamko, N., Geczy, C.L, Halliday, G.M · 2015 · Neuroscience
  33. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss
    Lee, Yunjong, Karuppagounder, Senthilkumar S, Shin, Joo-Ho, Lee, Yun-Il, Ko, Han Seok, Swing, Debbie, Jiang, Haisong, Kang, Sung-Ung, Lee, Byoung Dae, Kang, Ho Chul et al. · 2013 · Nature Neuroscience
  34. CHIP: a quality-control E3 ligase collaborating with molecular chaperones
    Murata, Shigeo, Chiba, Tomoki, Tanaka, Keiji · 2003 · The International Journal of Biochemistry &amp; Cell Biology
  35. The role of free radicals in the aging brain and Parkinson’s Disease: Convergence and parallelism
    Kumar, Hemant, Lim, Hyung-Woo, More, Sandeep Vasant, Kim, Byung-Wook, Koppula, Sushruta, Kim, In Su, Choi, Dong-Kug · 2012 · International Journal of Molecular Sciences
  36. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson’s disease
    Imam, Syed Z., Zhou, Qing, Yamamoto, Ayako, Valente, Anthony J., Ali, Syed F., Bains, Mona, Roberts, James L., Kahle, Philipp J., Clark, Robert A., Li, Senlin · 2011 · The Journal of Neuroscience
  37. Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition
    Maharjan, Sunita, Oku, Masahide, Tsuda, Masashi, Hoseki, Jun, Sakai, Yasuyoshi · 2014 · Scientific Reports
  38. Impaired dopamine release in Parkinson’s disease
    Cramb, Kaitlyn M L, Beccano-Kelly, Dayne, Cragg, Stephanie J, Wade-Martins, Richard · 2023 · Brain
  39. Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation
    Iguchi, Masahiro, Kujuro, Yuki, Okatsu, Kei, Koyano, Fumika, Kosako, Hidetaka, Kimura, Mayumi, Suzuki, Norihiro, Uchiyama, Shinichiro, Tanaka, Keiji, Matsuda, Noriyuki · 2013 · Journal of Biological Chemistry
  40. Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis.
    Tashiro, Yoshitaka, Urushitani, Makoto, Inoue, Haruhisa, Koike, Masato, Uchiyama, Yasuo, Komatsu, Masaaki, Tanaka, Keiji, Yamazaki, Maya, Abe, Manabu, Misawa, Hidemi et al. · 2012 · Journal of Biological Chemistry
  41. Point Mutations (Thr240Arg and Ala311Stop) in theParkinGene
    Hattori, Nobutaka, Matsumine, Hiroto, Asakawa, Shuichi, Kitada, Tohru, Yoshino, Hiroyo, Elibol, Blüent, Brookes, Anthony J., Yamamura, Yasuhiro, Kobayashi, Tomonori, Wang, Mei et al. · 1998 · Biochemical and Biophysical Research Communications
  42. The role of mitochondria in inherited neurodegenerative diseases
    Kwong, Jennifer Q., Beal, M. Flint, Manfredi, Giovanni · 2006 · Journal of Neurochemistry
  43. Dystonia in Parkinson’s disease
    Tolosa, Eduardo, Compta, Yaroslau · 2006 · Journal of Neurology
  44. Mitochondrial dysfunction in Parkinson's disease
    Schapira, A H V · 2007 · Cell Death &amp; Differentiation
  45. Effect of Wild-type or Mutant Parkin on Oxidative Damage, Nitric Oxide, Antioxidant Defenses, and the Proteasome
    Hyun, Dong-Hoon, Lee, MoonHee, Hattori, Nobutaka, Kubo, Shin-Ichiro, Mizuno, Yoshikuni, Halliwell, Barry, Jenner, Peter · 2002 · Journal of Biological Chemistry
  46. Protein neddylation and its role in health and diseases
    Zhang, Shizhen, Yu, Qing, Li, Zhijian, Zhao, Yongchao, Sun, Yi · 2024 · Signal Transduction and Targeted Therapy
  47. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases
    Nakamura, Tomohiro, Prikhodko, Olga A., Pirie, Elaine, Nagar, Saumya, Akhtar, Mohd Waseem, Oh, Chang-Ki, McKercher, Scott R., Ambasudhan, Rajesh, Okamoto, Shu-ichi, Lipton, Stuart A. · 2015 · Neurobiology of Disease
  48. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1)
    Kim, Jaekwang, Fiesel, Fabienne C., Belmonte, Krystal C., Hudec, Roman, Wang, Wang-Xia, Kim, Chaeyoung, Nelson, Peter T., Springer, Wolfdieter, Kim, Jungsu · 2016 · Molecular Neurodegeneration
  49. Metabolic Activity Determines Efficacy of Macroautophagic Clearance of Pathological Oligomeric α-Synuclein
    Yu, Wai Haung, Dorado, Beatriz, Figueroa, Helen Yvette, Wang, Lili, Planel, Emmanuel, Cookson, Mark R., Clark, Lorraine N., Duff, Karen E. · 2009 · The American Journal of Pathology
  50. Autophagy protects the retina from light-induced degeneration
    Chen, Yu, Sawada, Osamu, Kohno, Hideo, Le, Yun-Zheng, Subauste, Carlos, Maeda, Tadao, Maeda, Akiko · 2013 · Journal of Biological Chemistry
  51. Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons
    Evans, Chantell S, Holzbaur, Erika LF · 2020 · eLife
  52. Protein Folding in the Endoplasmic Reticulum and the Unfolded Protein Response
    Zhang, K., Kaufman, R.J. · 2005 · Handbook of Experimental Pharmacology
  53. HSP72 Is a Mitochondrial Stress Sensor Critical for Parkin Action, Oxidative Metabolism, and Insulin Sensitivity in Skeletal Muscle
    Drew, Brian G., Ribas, Vicente, Le, Jamie A., Henstridge, Darren C., Phun, Jennifer, Zhou, Zhenqi, Soleymani, Teo, Daraei, Pedram, Sitz, Daniel, Vergnes, Laurent et al. · 2014 · Diabetes
  54. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation
    Simon, D.K., Pulst, S.M., Sutton, J.P., Browne, S.E., Beal, M.F., Johns, D.R. · 1999 · Neurology
  55. Dystonia and parkinsonism
    Jankovic, Joseph, Tintner, Ron · 2001 · Parkinsonism &amp; Related Disorders
  56. Impaired dopamine release and synaptic plasticity in the striatum of <i>Parkin</i>−/− mice
    Kitada, Tohru, Pisani, Antonio, Karouani, Maha, Haburcak, Marian, Martella, Giuseppina, Tscherter, Anne, Platania, Paola, Wu, Bei, Pothos, Emmanuel N., Shen, Jie · 2009 · Journal of Neurochemistry
  57. Mitochondrial quality control by the Pink1/Parkin system
    Rüb, Cornelia, Wilkening, Anne, Voos, Wolfgang · 2017 · Cell and Tissue Research
  58. General aspects of neurodegeneration
    Jellinger, K. A. · 2003 · Journal of Neural Transmission. Supplementa
  59. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease
    Simon, David K, Lin, Michael T, Zheng, Leiya, Liu, Guang-Jun, Ahn, Colette H, Kim, Lauren M, Mauck, William M, Twu, Florence, Beal, M.Flint, Johns, Donald R · 2004 · Neurobiology of Aging
  60. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
    Gustavsson, Emil K, Follett, Jordan, Trinh, Joanne, Barodia, Sandeep K, Real, Raquel, Liu, Zhiyong, Grant-Peters, Melissa, Fox, Jesse D, Appel-Cresswell, Silke, Stoessl, A Jon et al. · 2024 · The Lancet Neurology
  61. Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons
    Ren, Yong, Jiang, Houbo, Hu, Zhixing, Fan, Kevin, Wang, Jun, Janoschka, Stephen, Wang, Xiaomin, Ge, Shaoyu, Feng, Jian · 2015 · Stem Cells
  62. Disease model organism for Parkinson disease: <i>Drosophila melanogaster</i>
    Aryal, Binod, Lee, Youngseok · 2019 · BMB Reports
  63. Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease
    Mullin, Stephen, Schapira, Anthony H.V. · 2015 · Neurologic Clinics
  64. Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
    Mendes-Pinheiro, Bárbara, Anjo, Sandra I., Manadas, Bruno, Da Silva, Jorge D., Marote, Ana, Behie, Leo A., Teixeira, Fábio G., Salgado, António J. · 2019 · Frontiers in Bioengineering and Biotechnology
  65. PINK1 Is Dispensable for Mitochondrial Recruitment of Parkin and Activation of Mitophagy in Cardiac Myocytes
    Kubli, Dieter A., Cortez, Melissa Q., Moyzis, Alexandra G., Najor, Rita H., Lee, Youngil, Gustafsson, Åsa B. · 2015 · PLOS ONE
  66. Genome-wide CRISPR screen for PARKIN regulators reveals transcriptional repression as a determinant of mitophagy
    Potting, Christoph, Crochemore, Christophe, Moretti, Francesca, Nigsch, Florian, Schmidt, Isabel, Manneville, Carole, Carbone, Walter, Knehr, Judith, DeJesus, Rowena, Lindeman, Alicia et al. · 2018 · Proceedings of the National Academy of Sciences
  67. Proteasome activation delays aging in vitro and in vivo
    Chondrogianni, Niki, Sakellari, Marianthi, Lefaki, Maria, Papaevgeniou, Nikoletta, Gonos, Efstathios S. · 2014 · Free Radical Biology and Medicine
  68. Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging
    Cho, Zang‐Hee, Oh, Se‐Hong, Kim, Jong‐Min, Park, Sung‐Yeon, Kwon, Dae‐Hyuk, Jeong, Hye‐Jin, Kim, Young‐Bo, Chi, Je‐Geun, Park, Chan‐Woong, Huston, John et al. · 2011 · Movement Disorders
  69. Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome
    Charlett, A., Dobbs, R. J., Dobbs, S. M., Weller, C., Brady, P., Peterson, D.W. · 2009 · Acta Neurologica Scandinavica
  70. In mammalian skeletal muscle, phosphorylation of TOMM22 by protein kinase CSNK2/CK2 controls mitophagy
    Kravic, Bojana, Harbauer, Angelika B., Romanello, Vanina, Simeone, Luca, Vögtle, F.-Nora, Kaiser, Tobias, Straubinger, Marion, Huraskin, Danyil, Böttcher, Martin, Cerqua, Cristina et al. · 2018 · Autophagy
  71. Selective Autophagy Receptors in Neuronal Health and Disease
    Conway, Owen, Akpinar, Hafize Aysin, Rogov, Vladimir V., Kirkin, Vladimir · 2020 · Journal of Molecular Biology
  72. Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy
    Liu, Jia, Wang, Xue, Lu, Yongquan, Duan, Chunli, Gao, Ge, Lu, Lingling, Yang, Hui · 2017 · Cell Death &amp; Disease
  73. Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease
    Noureddine, Maher A., Qin, Xue-Jun, Oliveira, Sofia A., Skelly, Tara J., van der Walt, Joelle, Hauser, Michael A., Pericak-Vance, Margaret A., Vance, Jeffery M., Li, Yi-Ju · 2005 · Human Genetics
  74. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
    Kawahata, Ichiro, Fukunaga, Kohji · 2020 · International Journal of Molecular Sciences
  75. Parkinson’s disease: a rethink of rodent models
    Melrose, Heather L., Lincoln, Sarah J., Tyndall, Glenn M., Farrer, Matthew J. · 2006 · Experimental Brain Research
  76. Involvement of Endoplasmic Reticulum Stress on the Cell Death Induced by 6-Hydroxydopamine in Human Neuroblastoma SH-SY5Y Cells
    Yamamuro, Akiko, Yoshioka, Yasuhiro, Ogita, Kiyokazu, Maeda, Sadaaki · 2006 · Neurochemical Research
  77. Impact of Reactive Species on Amino Acids—Biological Relevance in Proteins and Induced Pathologies
    Andrés, Celia María Curieses, Pérez de la Lastra, José Manuel, Andrés Juan, Celia, Plou, Francisco J., Pérez-Lebeña, Eduardo · 2022 · International Journal of Molecular Sciences
  78. Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin
    Charan, R A, Johnson, B N, Zaganelli, S, Nardozzi, J D, LaVoie, M J · 2014 · Cell Death &amp; Disease
  79. A novel brain-enriched E3 ubiquitin ligase RNF182 is up regulated in the brains of Alzheimer's patients and targets ATP6V0C for degradation
    Liu, Qing, Lei, Joy X, Sikorska, Marianna, Liu, Rugao · 2008 · Molecular Neurodegeneration
  80. Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
    González-Hernández, Tomás · 2010 · Frontiers in Neuroanatomy
  81. Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?
    Cebrián, Carolina, Loike, John D., Sulzer, David · 2014 · Current Topics in Behavioral Neurosciences
  82. PACRG and FAP20 form the inner junction of axonemal doublet microtubules and regulate ciliary motility
    Dymek, Erin E., Lin, Jianfeng, Fu, Gang, Porter, Mary E., Nicastro, Daniela, Smith, Elizabeth F. · 2019 · Molecular Biology of the Cell
  83. Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson’s disease-like motor dysfunction
    Suda, Yukari, Kuzumaki, Naoko, Sone, Takefumi, Narita, Michiko, Tanaka, Kenichi, Hamada, Yusuke, Iwasawa, Chizuru, Shibasaki, Masahiro, Maekawa, Aya, Matsuo, Miri et al. · 2018 · Molecular Brain
  84. Recent progress in the role of autophagy in neurological diseases
    Meng, Tian, Lin, Shiyin, Zhuang, Haixia, Huang, Haofeng, He, Zhengjie, Hu, Yongquan, Gong, Qing, Feng, Du · 2019 · Cell Stress
  85. Roles of LIM kinases in central nervous system function and dysfunction
    Cuberos, H., Vallée, B., Vourc'h, P., Tastet, J., Andres, C.R., Bénédetti, H. · 2015 · FEBS Letters
  86. Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease
    Choudhury, Saptamita Paul, Bano, Sarika, Sen, Srijon, Suchal, Kapil, Kumar, Saroj, Nikolajeff, Fredrik, Dey, Sanjay Kumar, Sharma, Vaibhav · 2022 · npj Parkinson's Disease
  87. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
    Magdalinou, N.K., Noyce, A.J., Pinto, R., Lindstrom, E., Holmén-Larsson, J., Holtta, M., Blennow, K., Morris, H.R., Skillbäck, T., Warner, T.T. et al. · 2017 · Parkinsonism &amp; Related Disorders
  88. Rifampicin Attenuates the MPTP-Induced Neurotoxicity in Mouse Brain
    Oida, Y., Kitaichi, K., Nakayama, H., Ito, Y., Fujimoto, Y., Shimazawa, M., Nagai, H., Hara, H. · 2006 · Brain Research
  89. A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling
    Shiba-Fukushima, Kahori, Inoshita, Tsuyoshi, Sano, Osamu, Iwata, Hidehisa, Ishikawa, Kei-ichi, Okano, Hideyuki, Akamatsu, Wado, Imai, Yuzuru, Hattori, Nobutaka · 2020 · iScience
  90. Regulation of RNF144A E3 ubiquitin ligase activity by self-association through its transmembrane domain
    Ho, Shiuh-Rong, Lee, Yu-Ju, Lin, Weei-Chin · 2015 · Journal of Biological Chemistry
  91. Strategies to Investigate Ubiquitination in Huntington's Disease
    Sap, Karen A., Reits, Eric A. · 2020 · Frontiers in Chemistry
  92. Crystal structure of human PACRG in complex with MEIG1 reveals roles in axoneme formation and tubulin binding
    Khan, Nimra, Pelletier, Dylan, McAlear, Thomas S., Croteau, Nathalie, Veyron, Simon, Bayne, Andrew N., Black, Corbin, Ichikawa, Muneyoshi, Khalifa, Ahmad Abdelzaher Zaki, Chaaban, Sami et al. · 2021 · Structure
  93. A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson’s disease patients.
    Wahl, Claudia, Kautzmann, Sabine, Krebiehl, Guido, Strauss, Karsten, Woitalla, Dirk, Müller, Thomas, Bauer, Peter, Riess, Olaf, Krüger, Rejko · 2008 · Journal of Neural Transmission
  94. Microtubule binding protein PACRG plays a role in regulating specific ciliary dyneins during microtubule sliding
    Mizuno, Katsutoshi, Dymek, Erin E., Smith, Elizabeth F. · 2016 · Cytoskeleton
  95. Parkin is dispensable for mitochondrial function, but its ubiquitin ligase activity is critical for macroautophagy and neurotransmitters: therapeutic potential beyond Parkinson's disease
    Moussa, Charbel E.-H. · 2015 · Neurodegenerative Diseases
  96. Mitochondrial Function and Neurodegenerative Diseases
    Wilkins, Heather M., Weidling, Ian, Koppel, Scott, Wang, Xiaowan, von Schulze, Alex, Swerdlow, Russell H. · 2018 · The Molecular and Cellular Basis of Neurodegenerative Diseases